Compound class:
Synthetic organic
Comment: The chemical structure for elunonavir was obtained from WHO Proposed list 125. The IUPAC>SMILES conversion maps to PubChem CID 135301900. Via SureChEMBL we can trace this compound to a Gilead Sciences patent that claims antiviral compounds for the treatment of HIV [1]. From the patent it would appear that elunonavir is an HIV protease inhibitor.
|
|
Bioactivity Comments |
We await formal disclosure of elunonavir's chemical structure and research code to provide details of its molecular mechanism of action and biological activity. |